Group One Trading
IMUC

Group One Trading’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Group One Trading’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-18
Closed – – 5934
2016
Q3 		$0 Hold
18
– – ﹤0.01% 6052
2016
Q2 		$0 Buy
18
+1
+6% +$10 ﹤0.01% 6029
2016
Q1 		$0 Buy
+17
New +$191 ﹤0.01% 6104
2015
Q4 		– Hold
0
– – – 6194
2015
Q3 		– Sell
-160
Closed -$2.91K – 6250
2015
Q2 		$3K Sell
160
-5
-3% -$96 ﹤0.01% 4647
2015
Q1 		$3K Sell
165
-61
-27% -$1.53K ﹤0.01% 4537
2014
Q4 		$7K Sell
226
-294
-57% -$8.46K ﹤0.01% 4388
2014
Q3 		$19K Sell
520
-47
-8% -$1.81K ﹤0.01% 4157
2014
Q2 		$25K Buy
+567
New +$27.4K ﹤0.01% 4030
2014
Q1 		– Sell
-4,003
Closed -$196K – 6556
2013
Q4 		$148K Buy
4,003
+133
+3% +$12.6K 0.02% 2698
2013
Q3 		$398K Buy
3,870
+2,727
+239% +$299K 0.05% 1816
2013
Q2 		$89K Buy
+1,143
New +$109K 0.01% 2925

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return